# Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients

> **NCT03850028** · NA · WITHDRAWN · sponsor: **University Medical Center Groningen**

## Conditions studied

- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

## Interventions

- **OTHER:** 89Zr-atezolizumab PET scans

## Key facts

- **NCT ID:** NCT03850028
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-22
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Closed prematurely because the accrual was not achieved
- **Last updated:** 2023-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03850028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03850028, "Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03850028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*